Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HTLV-1”

61 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 61 results

Not applicableStudy completedNCT01651819
What this trial is testing

Urological Physical Therapy in HTLV-1 With Urinary Symptoms

Who this might be right for
Tropical Spastic ParaparesisHTLV-1
Hospital Universitário Professor Edgard Santos 20
Large-scale testing (Phase 3)UnknownNCT01343355
What this trial is testing

Efficacy and Safety of Tamibarotene(AM80H) for HTLV-1 Associated Myelopathy/ Tropical Spastic Paraparesis (HAM/TSP)

Who this might be right for
HTLV-I-Associated Myelopathy
St. Marianna University School of Medicine 15
Not applicableStudy completedNCT03146013
What this trial is testing

Dual Algorithm Post Market Clinical Study

Who this might be right for
HTLV-I InfectionsHTLV-II InfectionsHuman T-lymphotropic Virus 1+3 more
MP Biomedicals, LLC 100
Early research (Phase 1)Study completedNCT00076843
What this trial is testing

Hu Mik-Beta-1 to Treat HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis

Who this might be right for
HTLV-1
National Institute of Neurological Disorders and Stroke (NINDS) 9
Testing effectiveness (Phase 2)Ended earlyNCT03075553
What this trial is testing

Nivolumab in Treating Patients With Relapsed or Refractory Peripheral T-cell Lymphoma

Who this might be right for
Blastic Plasmacytoid Dendritic Cell NeoplasmHepatosplenic T-Cell LymphomaHTLV-1 Infection+14 more
Mayo Clinic 12
Testing effectiveness (Phase 2)Ended earlyNCT00117845
What this trial is testing

Phase II Study of the Efficacy and Toxicity of Ontak(Registered Trademark) (Denileukin Diftitox) in the Therapy of Adult T-Cell Leukemia

Who this might be right for
Leukemia, Adult T-Cell
National Cancer Institute (NCI) 17
Testing effectiveness (Phase 2)Study completedNCT02631746
What this trial is testing

Nivolumab in Treating Patients With HTLV-Associated T-Cell Leukemia/Lymphoma

Who this might be right for
Acute Adult T-Cell Leukemia/LymphomaAdult T-Cell Leukemia/LymphomaChronic Adult T-Cell Leukemia/Lymphoma+3 more
National Cancer Institute (NCI) 3
Large-scale testing (Phase 3)Study completedNCT01472263
What this trial is testing

Use of Pentoxifylline in Human T-lymphotropic Virus Type-1 (HTLV-1) Diseases

Who this might be right for
HTLV-1Tropical Spastic ParaparesisImmune System Diseases+2 more
Hospital Universitário Professor Edgard Santos 48
Not applicableStudy completedNCT01941680
What this trial is testing

High Risk Adult T-cell Leukemia/Lymphoma (ATLL-HR) and Allogeneic Transplant

Who this might be right for
T-cell LymphomaLeukaemia
University Hospital Center of Martinique 20
Post-approval studies (Phase 4)Study completedNCT06616675
What this trial is testing

Darifenacin x Parasacral Transcutaneous Electric Nerve Stimulation for OAB in Patients Infected With Human T-Lymphotropic Virus 1

Who this might be right for
HTLV-1Overactive Bladder Syndrome
Hospital Universitário Professor Edgard Santos 42
Not applicableStudy completedNCT00034723
What this trial is testing

MRI Brain Studies in Patients With HTLV-1 Associated Myelopathy/Tropical Spastic Paraparesis

Who this might be right for
Tropical Spastic Paraparesis
National Institute of Neurological Disorders and Stroke (NINDS) 40
Not applicableStudy completedNCT01050881
What this trial is testing

Notification of Donors With Positive Microbiology Markers

Who this might be right for
Human Immunodeficiency VirusHepatitis BHepatitis C+2 more
NHS Blood and Transplant 217
Not applicableStudy completedNCT00339807
What this trial is testing

Natural History of HTLV-I Infection: Prospective Follow-up of a Cohort of Blood Donors in Jamaica

Who this might be right for
HTLV-I
National Cancer Institute (NCI) 1,500
Not applicableStudy completedNCT02439918
What this trial is testing

Epidemic History and Iatrogenic Transmission of Blood-borne Viruses in Mid-20th Century Kinshasa

Who this might be right for
HIVHTLV-1Hepatitis C, Chronic
Université de Sherbrooke 839
Early research (Phase 1)Temporarily pausedNCT04301076
What this trial is testing

Testing the Addition of an Anti-cancer Drug, Lenalidomide, to the Usual Combination Chemotherapy Treatment ("EPOCH") for Adult T-Cell Leukemia-Lymphoma (ATLL)

Who this might be right for
Acute Adult T-Cell Leukemia/LymphomaAdult T-Cell Leukemia/LymphomaChronic Adult T-Cell Leukemia/Lymphoma+1 more
National Cancer Institute (NCI) 30
Testing effectiveness (Phase 2)Study completedNCT01274533
What this trial is testing

Lenalidomide in HTLV-1 Adult T-Cell Leukemia

Who this might be right for
Adult T Cell Leukemia/Lymphoma
Columbia University 4
Testing effectiveness (Phase 2)Study completedNCT00061048
What this trial is testing

Campath-1H for Treating Adult T-Cell Leukemia/Lymphoma

Who this might be right for
Acute T-Cell Leukemia-Lymphoma
National Cancer Institute (NCI) 29
Not applicableStudy completedNCT00097006
What this trial is testing

Retrovirus Epidemiology Donor Study-II (REDS-II)

Who this might be right for
Acquired Immunodeficiency SyndromeBlood DonorsBlood Transfusion+10 more
National Heart, Lung, and Blood Institute (NHLBI)
Post-approval studies (Phase 4)Study completedNCT01418430
What this trial is testing

Pilot Study of Combination Therapy With CHOP-Zenapax (CHOP-daclizumab)

Who this might be right for
HTLV-I Associated Adult T-cell Leukaemia/Lymphoma (ATLL)
King's College Hospital NHS Trust
Testing effectiveness (Phase 2)Ended earlyNCT04362007
What this trial is testing

A Phase I/II Study of ASTX660 in Patients With Relapsed or Refractory T-cell Lymphoma

Who this might be right for
Relapsed or Refractory Peripheral T-cell Lymphoma(PTCL),Cutaneous T-cell Lymphoma(CTCL),Adult T-cell Leukemia/Lymphoma(ATLL)
Otsuka Pharmaceutical Co., Ltd. 8
Load More Results